Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme

Grade IV astrocytoma, termed glioblastoma multiforme (GBM) is one the most aggressive malignancies known to man. Despite intensive therapies, the median survival has remained approximately 15months. One of the major challenges to the treatment of CNS malignancies is the blood brain barrier (BBB). The barrier is designed to be incredibly selective, which means few therapeutics given to patients will reliably arrive at the site of the malignancy. To overcome the BBB and low blood flow that tends to occur within these tumors, various biodegradable materials, polymers and nanoparticles that can slowly release therapeutics at the site of the tumor have been developed.

Abstract licence: CC BY-NC

10 more references, whose wording the paper’s licence keeps private.

• Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications · 2020

• Stem cells in cancer therapy: opportunities and challenges · 2017

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.